deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT03066440

Double Blinded Randomized Control Trial of Types of IVF in Children With DKA

A Single-center Randomized Double Blinded Control Trial of Intravenous Fluid Content in Children With Diabetic Ketoacidosis Admitted to the Pediatric Intensive Care Unit

Sponsor: State University of New York at Buffalo

Conditions Diabetic Ketoacidosis
Interventions Lactated Ringers Normal saline
Updated 13 times since 2017 Last updated: Jul 16, 2024 Started: Sep 1, 2018 Primary completion: Mar 18, 2024 Completion: Mar 18, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Shortage of potassium acetate for study intravenous fluids

Other terminated trials from State University of New York at Buffalo

See all terminations from State University of New York at Buffalo

Other Diabetic Ketoacidosis trials with similar outcome

Browse all Diabetic Ketoacidosis trials

Listed as NCT03066440, this PHASE4 trial focuses on Diabetic Ketoacidosis and remains terminated or withdrawn. Sponsored by State University of New York at Buffalo, it has been updated 13 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Mar 2017 – ~Oct 2017 · 7 months · monthly snapshot~Oct 2017 – ~May 2018 · 7 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Nov 2019 · 13 months · monthly snapshot~Nov 2019 – ~Dec 2020 · 13 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshot~Apr 2022 – ~May 2023 · 13 months · monthly snapshot~May 2023 – ~Apr 2024 · 11 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Apr 2024 — Jul 2024 [monthly]

    Terminated PHASE4

    Status: Suspended → Terminated

  4. May 2023 — Apr 2024 [monthly]

    Suspended PHASE4

  5. Apr 2022 — May 2023 [monthly]

    Suspended PHASE4

▶ Show 8 earlier versions

  1. Jan 2021 — Apr 2022 [monthly]

    Suspended PHASE4

  2. Dec 2020 — Jan 2021 [monthly]

    Suspended PHASE4

  3. Nov 2019 — Dec 2020 [monthly]

    Suspended PHASE4

    Status: Recruiting → Suspended

  4. Oct 2018 — Nov 2019 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  5. Jun 2018 — Oct 2018 [monthly]

    Not Yet Recruiting PHASE4

  6. May 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE4

    Status: Recruiting → Not Yet Recruiting · Phase: NA → PHASE4

  7. Oct 2017 — May 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  8. Mar 2017 — Oct 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • State University of New York at Buffalo
Data source: State University of New York at Buffalo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations